Hiring?
Logo

Biotech, 1st in its class

location_on

South East, USA

Short Summary

Biotech breakthrough diagnosing pulmonary diseases. Est. market size is 329m individuals, excluding COVID-19 affected. M&A event acquiring 61% equity stake. Strategic partners - major int'l institute & US university. Projected valuation is $500m.

Overview

Target
US$1,000,000
Minimum
US$10,000
Investment Raised
N/A
Previous Rounds US$6,000,000
Stage Pre-Startup/R&D
Investor Role Silent

Highlights

  • 1st in class pulmonary diagnostic treatment
  • Current patents exits for the US, EU & Canada
  • FDA characterizes it as "urgent care" development.
  • "Fast track" approval process allows for shortened distribution release
  • Future valuation projected at $500m+.
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.

Ask a question

Got a question about this project?

Sign up to view the full pitch

It's free to discover the next big thing

Already have an account?

Similar Projects

Global Pro
20% raised

Non & Psychoactive CBD

location_on Colombia

Medical cannabis is a new industry that is growing rapidly due to its extraordinary effectiveness in the treatment of different diseases, in addition to its application in the cosmetic industry and various other industries.

US$ 5,000,000

Target

US$ 1,000,000

Min per Investor

Global Pro
0% raised

3D Bioprinting

location_on North East, USA

* Cellular Life Sciences (CLS), a life sciences tools company with a portfolio of solutions spearheaded by 3D Bioprinting * Focused on cell-based therapies, regenerative medicine, advanced therapeutics, diagnostics development * Spinout from...

US$ 1,500,000

Target

US$ 500,000

Min per Investor

Pro
0% raised

AntiStress Medical Device

location_on Midwest, USA

Introducing PSONA, a stress-eliminating device that eliminates stress in an instant and brings soothing relief. Wear this device to reduce headaches, pain, anxiety, depression, etc. Call or email me to find out more

US$ 500,000

Target

US$ 50,000

Min per Investor

load one similar proposal